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Abstract
MicroRNA (miRNA) sponges are transcripts with repeated miRNA antisense sequences that can sequester miRNAs from
endogenous targets. MiRNA sponges are valuable tools for miRNA loss-of-function studies both in vitro and in vivo.W e
developed a fast and flexible method to generate miRNA sponges and tested their efficiency in various assays. Using a
single directional ligation reaction we generated sponges with 10 or more miRNA binding sites. Luciferase and AGO2-
immuno precipitation (IP) assays confirmed effective binding of the miRNAs to the sponges. Using a GFP competition assay
we showed that miR-19 sponges with central mismatches in the miRNA binding sites are efficient miRNA inhibitors while
sponges with perfect antisense binding sites are not. Quantification of miRNA sponge levels suggests that this is at least in
part due to degradation of the perfect antisense sponge transcripts. Finally, we provide evidence that combined inhibition
of miRNAs of the miR-17,92 cluster results in a more effective growth inhibition as compared to inhibition of individual
miRNAs. In conclusion, we describe and validate a method to rapidly generate miRNA sponges for miRNA loss-of-function
studies.
Citation: Kluiver J, Gibcus JH, Hettinga C, Adema A, Richter MKS, et al. (2012) Rapid Generation of MicroRNA Sponges for MicroRNA Inhibition. PLoS ONE 7(1):
e29275. doi:10.1371/journal.pone.0029275
Editor: K.T. Jeang, National Institute of Health, United States of America
Received October 14, 2011; Accepted November 23, 2011; Published January 6, 2012
Copyright:  2012 Kluiver et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the Dutch Cancer Society [KWF RUG 2006–2634 and RUG 2009–4279 to B.J.K. and A.v.d.B.], the Vanderes Foundation
[VanderEs project 235 to J.K.] and in part by the National Science Foundation [NSF 0650991 to Y.D.]. The funders had no role in study design, data collection and
analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: j.l.kluiver@umcg.nl
Introduction
MicroRNAs (miRNAs) are involved in a multitude of biological
processes and diseases. For an in-depth understanding of miRNA
function it is imperative to have proper tools for gain- or loss-of-
function studies. Several methods have been developed to increase
miRNA expression, including miRNA precursor transfection, (viral)
vector based overexpression and the generation of transgenic
animals. For miRNA loss-of-function, the use of miRNA antisense
inhibitor oligonucleotides, knockouts and miRNA sponges have
been described [1–5]. Each of the techniques for inhibition of
miRNA activity has its specific advantages and disadvantages.
Inhibitor oligonucleotides are especially useful for short term
experiments while gene-knockouts allow studying the role of
miRNAs in vivo. However, the generation of knockout mice is time
consuming, costly and technically challenging as a large percentage
of miRNAs are located within protein-coding genes or are part of a
miRNA cluster. MiRNA sponges, i.e. in vivo expressed transcripts
that contain multiple miRNA antisense binding sites (MBS) to
sequester miRNAs, have been described as an alternative to the
generationofknockouts[6–8].In the firstpaper on miRNAsponges
by Ebert and colleagues it was shown that introduction of miRNA
sponges resulted in de-repression of miRNA targets in vitro [5]. In
Drosophila melanogaster miRNA sponges could accurately copy the
phenotype of loss-of-function mutants although the effects were
milder [9]. A sponge for miR-223 in bone marrow transplantation
assays could phenocopy several characteristics of a miR-223
knockout mouse [10].
Several miRNAs have seed family members at different loci that
may have overlapping functions. Studying the role of such
miRNAs using loss-of-function mutants may be difficult as all of
these loci may need to be targeted to accurately study its function.
MiRNA sponges can potentially inhibit all seed family members of
a miRNA and thus offers the additional advantage of studying the
function of a miRNA seed family. Furthermore, by introducing
multiple different MBS, e.g. MBS for all miRNAs of a specific
miRNA cluster, sponge technology can also be used to study the
role of different miRNAs simultaneously.
Sponges with an imperfect MBS, i.e. a MBS that include a 4
nucleotide (nt) central bulge (‘‘bulged sponges’’), are reported to be
more effective for the sequestration of miRNAs than sponges with
perfect antisense MBS [5,10,11]. This may be caused by
degradation of the sponge transcripts due to endonucleolytic
cleavage activity of AGO2 upon perfect binding of the miRNA
[12,13]. On the other hand, several other studies have reported
efficient inhibitory activity of perfect antisense sponges
[5,10,14,15]. The number of MBS in a sponge is also crucial for
their effectiveness [16,17]. More MBS increases the likelihood of
reaching maximal miRNA sequestration but it may also increase
the chance of sponge transcript degradation.
Two different strategies have been described for cloning of
miRNA sponges containing multiple MBS. The first approach is
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followed by the subsequent ligation of 59 and 39adapters [5]. The
resulting products are gel-purified, digested with the appropriate
restriction enzymes and cloned to the vector. In the second
approach long oligos that allow 2 (,50-mers) or 4 MBS (,100-
mers) are designed with appropriate overhangs to allow direct
directional cloning [7,16]. Although functional sponges can be
generated with these methods they both entail drawbacks. The
first method is relatively labor intensive and inefficient due to the
non-directional cloning approach. The second method allows
incorporation of only a limited number of MBS in the miRNA
sponge due to size limitations and is relatively expensive due to the
extraordinary length of such oligos.
Here, we describe and validate a protocol that allows rapid and
efficient generation of miRNA sponges with varying sizes using a
single ligation reaction. We tested the effectiveness of these bulged
and perfect sponges with different numbers of MBS in reporter
and proliferation assays. In addition, we also used a minigene
approach to inhibit all individual members of the miR-17,92
cluster simultaneous and show that combined inhibition of all
miRNAs of this cluster results in a more severe phenotype than
inhibition of individual miRNAs.
Results
To enable directional cloning of the oligo duplexes we inserted a
SanDI site in the pMSCV-PIG vector which will result in non-
palindromic overhangs upon digestion. By ligating oligo duplexes
with SanDI compatible ends with SanDI digested pMSCV-PIG-
sp, sponge constructs with a variable number of MBS were
generated in a single ligation reaction (Fig. 1a). This ligation
strategy was performed with sponge oligo duplexes for miR-19
(bulged and perfect), miR-92a and miR-155 using vector to duplex
ratios of 1:3, 1:100, 1:300 and 1:1000. The compiled result of the
PCR based screening of in total 94 colonies is shown in Figure 1b.
By increasing the ratio between vector and oligo duplexes from a
1:3 ratio to a 1:1000 ratio, the average number of MBS increased
from 3.2 (range 2–8) to 7.5 (range 2–22). Within the 1:1000 ratio
ligation 29% of all analyzed clones had 10 or more MBS. Sanger
sequencing of 10 clones with different inserts and insert lengths
confirmed for all clones the expected number of MBS in the
correct orientation. This shows that our method is a fast and
efficient method allowing generation of miRNA sponges with a
variable number of MBS.
To show that sponges generated by this method are fully
functional, we performed several experiments. MiR-19 sponge
variants containing 2–20 of either perfect or bulged MBS were
used to test whether perfect or bulged MBS sponges are more
effective. First we used the PITA and STarMir miRNA binding
energy prediction algorithms to determine how favorable it is for
miR-19 to bind to the miR-19 perfect and bulged MBS sponges
compared to known proven endogenous miRNA-19 targets. Both
algorithms predicted that miR-19a and miR-19b bind with a
much lower DDG/DGtotal to the sponge MBS than to the MBS of
seven proven endogenous targets (Fig. S1) [18,19]. As expected, a
lower DDG/DGtotal was calculated for the perfect MBS sponge as
compared to the bulged MBS sponge.
We confirmed binding of miR-19 to the MBS sequences by
inserting these sequences in a luciferase reporter vector and
perform luciferase based assays in HEK293 cells that endoge-
nously express miR-19a and miR-19b at high levels (up to 10% of
all miRNAs [20]). Compared to the empty vector, reporter vectors
with 2 perfect MBS sequences showed .25 fold lower Renilla/
Firefly (R/F) ratio while this was .9-fold for vectors with 2 bulged
MBS sequences (Fig. 2a). Decreasing R/F ratios were observed
with increasing number of MBS for both the perfect and bulged
MBS containing reporter vectors. To confirm that the observed
effects were indeed caused by binding of miR-19 to the MBS
sequences, we cotransfected cells with miR-19 inhibitors or
irrelevant miR-16 inhibitors and the reporter vector. This revealed
that repression of Renilla activity could be efficiently prevented
with miR-19 inhibitors but not with miR-16 inhibitors (Fig. 2b).
Thus, both perfect and bulged MBS containing reporter vectors
can efficiently bind miR-19 in a dose dependent way in a luciferase
reporter assay. Prevention of repression of Renilla activity upon
miR-19 inhibitor cotransfection was less effective in perfect MBS
reporter vectors as compared to bulged MBS reporter vectors.
One explanation for these differences is that they may be caused
by degradation of Renilla transcripts with perfect MBS resulting in
lower R/F ratios. Quantification of Renilla and Firefly transcripts
by qRT-PCR revealed similar Renilla and Firefly transcript levels
when comparing bulged and perfect MBS reporter constructs with
the same number of MBS (Fig. S2). Equal firefly levels show that
Figure 1. The rapid generation of miRNA sponges. (A) Schematic overview of the strategy to ligate miRNA sponge oligo duplexes into the
pMSCV-PIG-sp vector. Each oligo duplex contains 2 miRNA binding sites (MBS) and phosphorylated SanDI restriction enzyme compatible overhangs
to enable miRNA sponge generation in one single ligation reaction. SanDI overhangs are non-palindromic allowing for directional cloning of the oligo
duplexes. Arrows indicate transcription start sites. (B) Overview of the number of MBS per clone generated from ligation reactions with vector/duplex
ratios varying from 1:3 up to 1:1000. Per ratio the mean is indicated.
doi:10.1371/journal.pone.0029275.g001
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similar Renilla levels indicate that Renilla transcripts with perfect
MBS do not seem to be subject to degradation. An alternative
explanation for the observed difference in prevention of Renilla
repression may be that the cotransfected miR-19 inhibitor oligos
are less efficient in preventing miR-19 to bind to the perfect MBS
sequences due to higher sequence complementarity.
MiR-19 is part of the oncogenic miR-17,92 cluster [21,22] and
has been shown to be crucial for the oncogenic properties of this
cluster in a murine Myc-driven B-cell lymphoma model [19,23].
Therefore, we determined to what extend our different miR-19
sponges could affect cell growth in murine WEHI-231 B-cell
lymphoma cells which express miRNAs of the miR-17,92 cluster
at high levels (Fig. S3). WEHI-231 cells were infected with bulged
and perfect miR-19 MBS sponge vectors and empty vector control
and the percentage of GFP+ cells within the mixed cell population
(30–60% infected cells 4 days after infection) was followed for 21
days. Inhibition of miR-19 with bulged MBS sponges could affect
cell growth (Fig. 3a). The bulged sponge with 2 MBS showed a mild
growth inhibitory effect. Sponges with 6 and 20 bulged MBS
showed almost identical strong significant negative effects (p-value
resp. ,0.05 and ,0.01) on cell growth with a 50% reduction in the
percentage of GFP+ cells in 14 days. In contrast, no growth
inhibition was observed for any of the perfect MBS sponges against
miR-19. Despite similar initial infection percentages as determined
by the percentage of GFP+ cells, the median fluorescence intensity
(MFI) is on average 2-fold lower in perfect MBS sponges compared
to EV and bulged MBS sponges (Fig. S4a and S4b). Since the
luciferase assay proved that miR-19 can bind to the perfect MBS
sponges we hypothesized that the lowered MFI observed for perfect
sponges may be due to sponge transcript degradation as a result of
perfect complementary miR-19 binding. Degradation of perfect
MBS sponge containing Renilla transcripts was not observed in the
luciferase experiments, however, this could be due to the fact that
transcript levels were measured already 24 h after transfection (at
the same time as the luciferase assay was performed). To test
whether degradation could explain our observations we sorted cells
infected with the bulged and perfect miR-19 MBS sponge vectors
and empty vector control (Fig. 3a) based on GFP fluorescence two
weeks after infection. Sponge transcript levels driven by the 59LTR
were quantified and compared to the GFP transcript levels which
can be transcribed independently from the PGK promoter. This
revealed that the ratio between sponge transcripts and GFP
transcripts was lowered for perfect MBS sponges compared to that
of the empty vector control, with the lowest ratio observed with 18
perfect MBS (.50% lower than empty vector, Fig. 3b and Fig. S5).
In contrast, sponge/GFP transcript ratios for bulged sponges
remained similar to empty vector control regardless of the number
of MBS. Thus, our results show that bulged sponges are more
effective for the prolonged inhibition of miRNAs than perfect
sponges most likely (at leastinpart)dueto degradation ofthe perfect
MBS containing transcripts.
To further prove the functionality of our sponges we tested if the
sponge transcripts, similar to endogenous miRNA targets, were
enriched in the AGO2 immunoprecipitation (IP) fraction.
Therefore, we infected the HL cell line KM-H2 that has high
levels of miR-155 [24] with a miR-155 sponge (bulged, 14 MBS)
and performed AGO2-IP. Quantitative RT-PCR showed that the
sponge transcripts are indeed strongly enriched in the AGO2-IP
fraction and not in the IgG control IP (Fig. 3c). Thus, similar to
endogenous miRNA targets sponge transcripts are bound to
AGO2 containing RISC complexes.
Next, we analyzed the effect of individual members of the miR-
17,92 cluster on WEHI-231 cells using bulged sponges. This
revealed that all miRNAs of this cluster can individually influence
WEHI-231 cell growth (Fig. 3d). A .50% reduction in GFP+ cells
was observed within 18 days for all except the sponge construct
against miR-18a which induced a 35% reduction of GFP+ cells.
Almost identical curves were observed for the sponges that inhibit
miR-17-5p and miR-20a, both members of the miR-17/106b seed
family. No effect was observed for the empty vector control. To
determine whether miRNAs of this cluster cooperatively act in the
regulation of WEHI-231 growth we also designed 2 combination
(combi)-sponges (combi-sp1 and -sp2). Both combi-sponges con-
tained 3 MBS for each miRNA seed family of this cluster, i.e. miR-
17, miR-18a, miR-19 and miR-92a, and only differed in the spacer
sequences in between the MBS. PITA analyses predicted, based on
,equal sum of DDG, that both sponges would bind the
Figure 2. Confirmation of miR-19 binding to miR-19 sponge constructs. (A) Luciferase reporter assays in HEK293 cells reveal that repression
of Renilla activity is more prominent in reporter vectors that contain perfect MBS sequences as compared to reporter vectors that encode bulged
MBS sequences and is in both cases dependent on the number of MBS. (B) Release of miR-19 specific repression of Renilla luciferase activity by anti-
miR-19a/b oligos confirms that miR-19 binds to the miR-19 MBS sequences. No release of luciferase activity is observed with a control anti-miR-16
oligo. Open bars: Mock, grey bars: miR-16 inhibitor and black bar: miR-19 inhibitor mix. For each graph the number of MBS per reporter vector is
indicated on the x-axis and on the y-axis the ratio of Renilla (R) over Firefly (F) luciferase is depicted. *=p-value ,0.05; **=p-value ,0.01; ***=p-
value ,0.001.
doi:10.1371/journal.pone.0029275.g002
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STarMir algorithm predicted that binding of miRNAs of the miR-
17,92 cluster to combi-sp1 would be energetically more favorable
than binding to combi-sp2 (,2-fold lower sum of DGtotal per
miRNA). GFP competition assays with the combi-sponges revealed
a strong decrease in cell growth, i.e. the percentage of GFP+ cells
was halved within 3 and 9 days for respectively combi-sp1 and
combi-sp2 (Fig. 3d). No effect on WEHI-231 cell growth was
observed for the control combi-sponge which existed of the exact
same nucleotide content as combi-sp1 with the miRNA seed
binding regions for each BS being scrambled.
Discussion
We developed a fast and efficient method to generate miRNA
sponges with variablenumbers ofMBS. Sponges withmorethanten
MBS can be easily generated within days. This makes our method
fast and cost effective compared to previously published methods.
Our method can also be used to inhibit two miRNAs simultaneously
by designing MBS for two different miRNAs within one oligo
duplex. In case more than two different MBS are desired it may be
more efficient to design the sponges as minigenes. Drawbacks of
minigenes are their costs and difficulties in synthesis that can be
encountered with repeated sequences as present in sponges. Using
various assays we showed that sponges generated using our method
are fully functional. Firstly, luciferase assays confirm that miRNAs
canbindtothespongesinadosedependentmanner.Secondly,GFP
assays show that the sponges can functionally inhibit miRNAs.
Thirdly, AGO2-IP showed that the sponges are enriched in the
AGO2-IP fraction, similar to endogenous targets.
Based on the long-term GFP competition assay with various miR-
19 sponges it is clear that miRNA sponges with bulged MBS
Figure 3. Bulged miRNA sponges can effectively inhibit miRNA function. (A) GFP competition assay in WEHI-231 B-cell lymphoma cells
infected with empty vector (EV), bulged and perfect miR-19 sponges. Bulged MBS sponges have mild (2 MBS) or strong effects (6 and 20 MBS) on cell
growth while perfect MBS sponges and the empty vector control have no effect. Legend: x=EV; D=P-2MBS; %=P-6MBS; #=P-18MBS; m=B-2MBS;
&= =B-6MBS; .=B-20MBS. (B) From the experiment shown in Fig. 3a, EV, perfect en bulged MBS sponge infected GFP+ cells were sorted at day 14.
Quantification of sponge (LTR driven) and GFP transcript levels (PGK driven) by qRT-PCR revealed lowered sponge/GFP transcript ratios for the perfect
sponges but not for the bulged sponges as compared to the empty vector control. The number of MBS per sponge vector is indicated on the x-axis.
(C) Quantification of sponge transcript levels in the AGO2-immunoprecipitated (IP) fraction of miR-155 sponge infected KM-H2 cells. AGO2-IP of miR-
155 sponge infected KM-H2 cells was performed and followed by quantification of miR-155 sponge transcript levels in total, flowthrough (FT) and IP
fraction of AGO2 and IgG IP experiments. MiR-155 sponge transcripts are highly enriched in the AGO2-IP fraction but not in the IgG-IP control
fraction. In the inset of the graph a Western Blot which shows that AGO2 levels are enriched in the IP fraction upon AGO2-IP but not in the IgG-IP
control. (D) GFP competition assay in WEHI-231 cells infected with individual bulged miRNA sponges against each member of the miR-17,92 cluster
and combination (combi-sp) sponges against each miRNA family of the miR-17,92 cluster. As a control, empty vector and a combi-sp vector with
seed scrambled miRNA BS (combi-scr) were used. All individual miRNA sponges show negative effects on cell growth, however, the strongest effects
are observed when all miRNAs of the miR-17,92 cluster are inhibited simultaneously. No effects on proliferation were observed with the empty
vector and combi-scr vector controls. Legend: x=EV; %=miR-17-5p-sp (12MBS); D=miR-18a-sp (10MBS); *=miR-19-sp (20MBS); ı=miR-20a-sp
(7MBS); #=miR-92a-sp (10MBS); &=Combi-sp1 (463MBS); m=Combi-sp2 (463MBS);N=Combi-scr (463MBSscr). *=p-value ,0.05; **=p-value
,0.01; ***=p-value ,0.001.
doi:10.1371/journal.pone.0029275.g003
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A limited effect on cell growth was observed using two bulged MBS
and similar strong effects were observed using sponge constructs
containing six and twenty MBS. Thus, in WEHI-231 cells
introduction of miR-19 sponges with six bulged MBS already
suffices for maximal miRNA inhibition. Depending on the level of
miRNA expression and the number and binding energy of
endogenous miRNA targets more or less MBS may suffice for
maximal miRNA inhibition [17]. In the case of miR-17 inhibition in
WEHI-231, sponges with twelve MBS showed a 2-fold faster
reductioninGFP+cellsascomparedtospongeswithfourMBS(data
not shown). No effects on cell growth were observed for perfect MBS
sponges regardless the number of MBS incorporated in the sponge
construct. The lower effectiveness of perfect sponges compared to
bulged sponges can at least in part be explained by the lower perfect
sponge RNA transcripts levels. It has been reported that upon
perfect miRNA binding, mRNAs are cleaved by the slicer activity of
the RISC complex [13]. Thus, although we do not show direct
cleavage of perfect MBS sponge transcripts it is likely that the perfect
MBS sponge transcript levels are lowered due to mRNA cleavage
and therefore are less suitable for miRNA inhibition. Nevertheless,
perfect MBS sequences are suitable for miRNA mediated downreg-
ulation of a specific transcript [25,26] as we show in our luciferase
reporter assay. Both PITA and STarMir predicted a more efficient
binding of miRNAs to perfect MBS sponges compared to bulged
MBS sponges consistent with the results obtained from the luciferase
assay. However, neither PITA nor STarMir take into consideration
the effects of sponge degradation upon binding of a perfectly
matched antisense miRNA. Thus, when designing sponges for long-
term miRNA inhibition one should not solely focus on the DDG/
DGtotal but also ensure that MBS are not perfect antisense.
Finally, we successfully used bulged sponges against each of the
miRNAs of the miR-17,92 cluster to determine the effect on cell
growth of each member in a GFP competition assay (Fig. 3d). This
revealed that inhibition of miR-92 was most effective for growth
inhibition followed by miR-17 and miR-20, miR-19 and miR-18
being the least effective. Elegant studies in a mouse model of B-cell
lymphoma showed that miR-19a and miR-19b were required and
largely sufficient for the oncogenic properties of the miR-17,92
cluster [19,23]. However, in WEHI-231 cells the twelve MBS
sponge against miR-92a resulted in a .26 faster reduction in
GFP+ cells than a twenty MBS sponge against miR-19. It is
unlikely that this is due to incomplete sequestration of miR-19
since sponges with six and twenty MBS showed similar effects in
the GFP competition assay indicating maximal miRNA inhibition
(Fig. 3a). Thus, our results suggest that in WEHI-231 miR-92a has
a more prominent role in regulating cell growth than miR-19. The
MBS of the miR-17 and miR-20 sponges differ at nt 1, 14 and 22,
the sequence between the MBS, and the number of MBS (resp. 12
and 7 BS). Nonetheless, the sponges against miR-17 and miR-20
are both approximately equally effective in growth inhibition in
the GFP competition assay. This is in line with the idea that
sponges can inhibit all miRNAs with the same seed sequence. The
two combination sponges against the entire miR-17,92 revealed
a 50% reduction of GFP+ cells after 3 and 9 days for combi-sp1
and combi-sp2 respectively. This denotes cooperation of the
individual miR-17,92 cluster members in promoting prolifera-
tion/oncogenic activity. The difference between combi-sp-1 and
combi-sp-2 is in the sequence of the 4 nt spacers between the
MBS. As a result, combi-sp-1 is predicted by STarMir to sequester
miRNAs more efficiently than combi-sp-2 which is consistent with
the faster reduction in GFP+ cells for combi-sp1.
In conclusion, we have developed a fast and efficient method to
generate miRNA sponges that can be applied to stably inhibit one
or more miRNAs. Luciferase, GFP competition and AGO2-IP
assays show that the sponges generated using our protocol are
efficient inhibitors of miRNAs. Our method will prove to be highly
valuable for studies that involve generating miRNA sponges to
study miRNA loss of function either in vitro or in vivo.
Materials and Methods
Cell lines
The Hodgkin lymphoma cell line KM-H2 was cultured in
RPMI 1640 supplemented with 2 mM ultra-glutamine, 100 U/ml
penicillin/streptomycin, and 10% fetal bovine serum (Cambrex
Biosciences, Walkersville, USA). For the murine WEHI-231 cell
line, 50 mM 2-mercaptoethanol was added as an extra additive.
Phoenix-ampho [27], HEK-293 and HEK-293T cells were
cultured in DMEM supplemented with 2 mM ultraglutamine,
100 U/ml penicillin/streptomycin, and 10% fetal bovine serum
(Cambrex Biosciences). All cell lines except Phoenix-ampho were
obtained from the DSMZ (KM-H2, HEK-293 and HEK-293T) or
ATCC (WEHI-231).
Individual miRNA sponge design
To enable directional cloning of repetitive miRNA BS sequences,
we designed oligo duplexes with overhangs that are compatible with
the restriction endonuclease SanDI [28]. This enzyme recognizes
the 7-bp interrupted palindrome 59-GGGWCCC-39 (W=A or T)
producing 3-nt long 59 protruding (GWC) that will enable
directional ligation of the oligo duplexes. Besides the phosphory-
lated SanDI compatible overhangs each oligo duplex contained 2
MBS separated by a 4 nt spacer sequence that were either perfect (-
P) antisense to the miRNA or contained a central 4 nt mismatch
(‘‘bulge’’, -B) to the miRNA. To optimize the sequence of our
sponges, two published algorithms, i.e. PITA (http://genie.
weizmann.ac.il/pubs/mir07/mir07_prediction.html, [29]) and
STarMir (http://sfold.wadsworth.org/cgi-bin/STarMir.pl were
used with standard settings [30]). For the in silico analyses, sponge
sequence and SanDI site flanking sequence starting from the end of
the psi packaging signal and ending at the start of the PGK
promoter of the pMSCV-PIG-sp vector (see below) were used (total
of 466 bp+sponge sequence). Based on different RNA folding
computations, both algorithms predict the effectiveness of the
designed MBS in the sponges by calculating the difference between
the free energy gained by binding of the miRNA to the MBS and
the free energy lost by unwinding of the MBS nucleotides (DDG
(PITA) and DGtotal (STarMiR)). The PITA algorithm also provides
information on all other miRNAs that can potentially bind to the
sponge sequence. This information was used to vary the sequence to
minimize off target miRNA binding. Variations that were tested
included varying the sequence and length of the spacer sequence
(sequence between to MBS) and switching between A and T
nucleotides in the middle of the SanDI recognition sequence.
Bulged MBS sponges were generated for miR-19, miR-92a and
miR-155. For miR-19 we also created perfect sponges. The miR-19
family consists of miR-19a and -19b that differ at nt 11 (U/C). To
allow perfect antisense binding of miR-19a as well as miR-19b we
designed the perfect sponges to have an equal number of MBS
against miR-19a and -19b (Table S1 and S2). The bulged miR-19
sponge contained identical MBS for miR-19a and miR-19b since
the differing nt 11 was within the central bulge.
MicroRNA combination sponges
Combination sponges for the miR-17,92 cluster containing 3
MBS for the miR-17, miR-18a, miR-19 and miR-92 family were
ordered as minigenes (IDT, Coralville, IO, USA) with 59-Xho1
Rapid Generation of MicroRNA Sponges
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sp1 and –sp2, full sequences in Table S2). For optimal design of
the minigenes, PITA and STarMir were used to predict which
variations in the spacer sequences between the MBS would result
in maximal MBS affinity. Two versions of the miR-17,92 sponge
were designed that differed in the spacer sequences (combi-sp1 -
TTAT- and combi-sp2 -GCGG- and -CGCC-). As a control, a
multisponge with scrambled miRNA seed binding regions was
designed (‘‘combi-scr’’, -TTAT- spacers).
MicroRNA sponge generation
MBS containing oligos with 59phosphates (Table S1) were
ordered PAGE purified at a 100 nmol scale (IDT). Oligos were
dissolved to 50 mM in STE
24 (100 mM NaCl, 10 mM Tris/HCL,
1 mM EDTA, pH 8.0). Sense and antisense oligos were mixed at a
1:1 ratio and annealed by incubation at 100uC for 10 minutes
followed by slow cooling. The pMSCV-PIG-sp vector was
generated by inserting a SanD1 restriction site containing linker
(Table S1) between the XhoI and EcoRI restriction sites of
pMSCV-PIG (Addgene, www.addgene.org, plasmid 21654).
pMSCV-PIG-sp was digested with SanD1 for 1 h at 37uC
(Fermentas, St. Leon-Rot, Germany) and dephosphorylated with
1 ml CIAP (1 U/ul, Invitrogen, Carlsbad, CA, USA) for 5 minutes
at 37uC. Enzymes were inactivated by incubation for 10 minutes
at 65uC. Ligation was performed with 50–100 ng gel-purified
vector and insert was added in different vector/oligo duplex ratios
varying from 1:3 to 1:1,000. The amount of insert needed per ratio
was calculated according to the formula: ng oligo duplex={(size
oligo duplex6ng vector)/size vector}6ratio. Ligation reactions
were performed in 20 ml with 5 U T4 DNA ligase (Invitrogen). To
determine the insert size, 10–20 colonies were screened by PCR
after transformation (for primers see Table S1). A random
selection of the constructs containing 1–10 oligo duplexes were
subjected to Sanger sequencing for validation (LGC Genomics,
Berlin, Germany). A sponge for miR-17-5p was generated using a
previously described protocol [5] (for full sponge sequences see
Table S2). Sponges for miR-18a and miR-20a (a kind gift from M.
Ebert, Koch Institute for Integrative Cancer Research, MIT,
USA) were subcloned into pMSCV-PIG-sp using XhoI and PmeI.
Luciferase assay
MiR-19 sponge sequences were subcloned from the pMSCV-
PIG-sp vector into the psiCHECK2 vector (Promega, Madison,
USA) using Xho-1 and Pme-1 restriction enzymes. Luciferase
reporter assays were performed as described previously [31].
Briefly, transfection of HEK293 cells was performed using the
Amaxa nucleofector I device (Amaxa, Gaithersburg, USA) with
solution V, program Q-01. One million HEK293 cells transfected
with 2 mg of each construct with or without a 2 nmol equal molar
mix of miR-19a and miR-19b inhibitor oligos or miR-16 inhibitor
as a control (for sequence and modifications see Table S1, Exiqon,
Vedbaek, Denmark) were harvested 24 h post transfection for dual
luciferase measurement. For each transfection the Renilla and
Firefly activity was measured in duplo and the average Renilla
over Firefly (R/L) ratio was calculated. All transfections were
performed in triplicate, and standard deviations were calculated.
Repeated measures ANOVA followed by a Dunnett’s multiple
comparison post test was performed for each construct to
determine whether there were significant differences in R/L ratios
between the empty vector and the MBS containing reporter
vectors. To calculate whether mock, miR-19 inhibitor or miR-16
inhibitor treatment significantly altered the R/L ratio of a reporter
vector we performed repeated measures ANOVA followed by
Tukey’s multiple comparison post test.
Retroviral infection
For the production of ecotropic retrovirus, 293 T cells were
CaPO4 transfected with 2.5 mg of retroviral expression vector and
2.5 mg pCL-Eco vector in 6 well format and virus was harvested
after 48 h. For the generation of amphotropic retrovirus, Phoenix-
Ampho cells were transfected with 37.5 mg vector in T75 flasks.
Virus was harvested after 2 days and concentrated with Retro-X
concentrator (Clontech, Saint-Germain-en-Laye, France) accord-
ing to the manufacturer’s protocol. For both pseudotyped viruses
target cells were infected by spinning at 2000 rpm with a final
polybrene concentration of 4 mg/ml for 2 hrs.
FACS analysis
For GFP competition assays WEHI-231 cells were freshly
infected (infection rate 25–70%, adjusted to max 50% GFP+
cells) and after 4 days GFP expression was monitored for three
weeks tri-weekly. Data were acquired on a FACS Calibur flow
cytometer (BD PharMingen) and analyzed using FlowJo software
(version 7.6, Treestar, Ashland, OR). The GFP percentage
determined at the first day of measurement (4 days post infection)
was set to 1. For each measurement the average decline per day
was calculated and used to determine whether the average
decline in GFP percentage was significant different from the
empty vector control (repeated measures one-way ANOVA, with
Dunnet’s multiple comparison post test, p-value ,0.05). Each
GFP competition assay was performed at least twice. For qRT-
PCR and AGO2-IP experiments infected cells were GFP sorted
,2 weeks after infection using a MoFlo sorter (Dako cytoma-
tion).
qRT-PCR analysis
Total RNA was isolated using Trizol (Invitrogen, Carlsbad,
CA). cDNA was made with 500 ng input RNA using SuperScript
II and random hexamers according to the manufacturers
protocol (Invitrogen). Quantitative PCR (qPCR) was performed
using primers that amplify a 56 bp region 39of the SanDI
restriction site resulting in specific detection of the sponge
transcript made from the 59LTR and primers that amplify a
57 bp region within the GFP transcript that can detect the PGK
promoter driven transcript and possibly ‘‘read-through’’ tran-
scripts from the 59LTR (for schematic overview of the used vector
see Fig. 1a and for primer sequences see Table S1). qPCR was
performed in triplicate in 20 ml reaction volumes containing
either 16SYBRgreen mix (Applied Biosystems, Foster City, CA,
USA), 300 nM primers, and 2 ng of cDNA (for sponge and GFP
transcript) or 16 PCR mix (Eurogentec, Maastricht, The
Netherlands) 900 nM pimers and 500 nM probe (for U6).
Reactions were performed on an ABI7900HT Sequence
Detection System device (Applied Biosystems) using the standard
program. Mean cycle threshold (Ct) values for all genes were
quantified with the SDS software (Applied Biosystems; version
2.1). Relative expression levels of sponge and GFP transcripts in
WEHI-231 cells were calculated by normalizing expression levels
to U6 resulting in a DCt from which the 2
2DCt was calculated.
For the quantification of Renilla and Firefly luciferase transcripts
in HEK293 cells relative expression levels were calculated by
normalizing to RPII. For the quantification of the miR-155
sponge transcript levels in the AGO2-IP analysis, Ct values were
corrected to equalize for the input of each fraction. qRT-PCR for
miRNA-17-5p, -18a, -19a, -19b, -20a and -92a were performed
using miRNA qRT-PCR assays (Applied Biosystems) according
to the manufacturer’s protocol. MiRNA expression levels were
normalized to the levels of snoRNA-429.
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Immunoprecipitation of AGO2-containing RISC complexes
was performed as published previously [32]. Briefly, 20 million
miR-155 sponge or empty vector infected sorted cells were lysed.
Cleared supernatant was incubated with protein G sepharose
beads coated with AGO2 antibody (Clone 2E12-1C9, Abnova,
Taiwan) or IgG control antibody at 4uC overnight. After washing
of the beads, RNA was harvested for qRT-PCR analysis and
protein lysates were made for Western blot analysis. AGO2
Western blotting was performed as described previously [32].
Supporting Information
Figure S1 Pita and STarMir analyses for miR-19 sponge
variants and seven proven miR-19 targets. Both algorithms
calculate the difference between the amount of energy needed to
make the MBS available for binding and the amount of energy
that is gained by base pairing of the miRNA to the MBS (DDG
(PITA) and DGtotal (STarMir), Y-axis). The predicted MBS within
the sponge sequence or within the 39UTR of endogenous targets
are ordered from low to high DDG/DGtotal. The majority of MBS
present in the miR-19 sponges are predicted to have a much lower
DDG/DGtotal than MBS in proven endogenous miR-19 targets.
Note 1: perfect BS sponges in the PITA analysis shows 12 MBS
instead of the expected 6 MBS due to the fact that nt 3–9 of miR-
19a and miR-19b are repeated at nt 13–19 and are therefore in
the perfect antisense sequence defined by PITA as potential MBS;
Note 2: no miR-19b MBS were predicted by STarMir for SBF2.
(TIF)
Figure S2 Renilla and Firefly luciferase quantification.
RNA was isolated from HEK293 cells, 24 h after transfection of
the luciferase reporter vector. Renilla (top) and Firefly (middle)
transcript levels were quantified to show that perfect and bulged
MBS reporter vectors with the same number of MBS are
expressed at similar levels. Renilla transcript levels normalized to
those for Firefly revealed no evidence for increased degradation of
Renilla transcripts in perfect MBS sponges as compared to bulged
MBS sponges (bottom).
(TIF)
Figure S3 Quantification of miRNAs of the miR-17,92
cluster in WEHI-231 cells. All miRNA levels of the miR-
17,92 cluster miRNAs were quantified and normalized to
snoRNA429. Lower levels were observed for miR-18a, interme-
diate levels for miR-17-5p, miR-19a, miR-19b and miR-20a and
higher levels for miR-92a.
(TIF)
Figure S4 Median fluorescence intensity (MFI) is lower
in perfect MBS sponges as compared to bulged MBS
sponges and empty vector at similar infection rates. (A)
GFP percentages at day 4 after infection of empty vector (EV,
open bars) and perfect (striped bars) and bulged (grey bars) sponges
with indicated amounts of MBS. (B) MFI for the same constructs
at the same time point. For each graph the number of MBS per
sponge vector is indicated on the x-axis.
(TIF)
Figure S5 Perfect MBS sponge transcripts levels are
lower than bulged sponge transcript levels. Two weeks
after infection WEHI-231 cells infected with miR-19 perfect and
bulged MBS sponges were sorted and RNA was isolated
(experiment shown in Fig. 3a). Sponge transcript (LTR driven,
top) quantification revealed that lower levels of sponge transcripts
are present in cells infected with the perfect MBS sponges
compared to bulged MBS sponges. GFP transcript levels (PGK
driven and not regulated by miR-19, middle) are similar for 6
MBS and 18/20 MBS sponges. The 2 MBS sponges showed a
,2,5 fold difference in GFP transcript levels between bulged and
perfect MBS sponges. Sponge transcript levels normalized to GFP
revealed that sponge transcript levels are consistently lower in
perfect MBS sponges compared to bulged MBS sponges and the
empty vector control (bottom).
(TIF)
Figure S6 Pita and STarMir analyses for combi-sp1 and
combi-sp2 sponges. For each miRNA of the miR-17,92
cluster, i.e. miR-17, miR-18a, miR-19a, miR-19b, miR-20a and
miR-92a, the sum of the DDG/DGtotal of all MBS is calculated. As
a control the combi-scr was also analyzed for predicted miRNA
binding. (A) The PITA algorithm predicts that binding of miR-
17,92 miRNAs to combi-sp1 or combi-sp2 is,equally energet-
ically favorable. (B) The STarMir algorithm predicts that miRNAs
of the cluster bind with a lower DGtotal to combi-sp1.
(TIF)
Table S1 Oligos used.
(XLS)
Table S2 Sponge sequences.
(DOC)
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